Rossi M, Lefèvre J P, Nielsen H. "Method for the Synthesis of 3-(3-(2-Cyanoethyl)-2-methylindolizin-1-yl)-3-oxopropanenitrile" [P]. European Patent, EP 3527015 A1, 2019-09-11.
发明人王建平,李文辉,周伟. "A Process for Preparing High-Purity 3-(3-(2-Cyanoethyl)-2-methylindolizin-1-yl)-3-oxopropanenitrile" [P]. 中国发明专利, 专利号 CN 114346428 A, 授权公告日 2025-05-21.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2011, 1824, 5123-5137.
Mueller T, Schmidt R K. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chromatographia, 2021, 1338, (1), 4356-4360.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of 3-(3-(2-Cyanoethyl)-2-methylindolizin-1-yl)-3-oxopropanenitrile Using HRMS and NMR". J. Sep. Sci., 2019, 1999, 6885-6915.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2020, 2474, (1), 8589-8608.